• DOI:10.1016/S0140-6736(10)62110-1
Corpus ID: 22950940

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

@article{Rothwell2011EffectOD,
  title={Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials},
  author={P. Rothwell and F. G. Fowkes and J. F. Belch and H. Ogawa and T. Meade},
  journal={The Lancet},
  year={2011},
  volume={377},
  pages={31-41}
}

P. Rothwell, F. G. Fowkes, +2 authors T. Meade

Published 2011

Medicine

The Lancet

BACKGROUND Treatment with daily aspirin for 5 years or longer reduces subsequent risk of colorectal cancer. Several lines of evidence suggest that aspirin might also reduce risk of other cancers, particularly of the gastrointestinal tract, but proof in man is lacking. We studied deaths due to cancer during and after randomised trials of daily aspirin versus control done originally for prevention of vascular events. METHODS We used individual patient data from all randomised trials of daily… CONTINUE READING

View on Elsevier

gwern.net

Save to Library

Create Alert

Cite

Launch Research Feed